AAAAAA

   
Results: 1-10 |
Results: 10
CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
Authors: SOSMAN JA ARONSON FR SZNOL M ATKINS MB DUTCHER JP WEISS GR ISAACS RE MARGOLIN KA FISHER RI ERNEST ML MIER J OLEKSOWICZ L ECKHARDT JR LEVITT D DOROSHOW JH
Citation: Ja. Sosman et al., CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY, Clinical cancer research, 3(1), 1997, pp. 39-46
EPOCH CHEMOTHERAPY FOR RECURRENT LYMPHOMA
Authors: CASE DC ARONSON FR ERVIN TJ EBRAHIM KS BOYD M
Citation: Dc. Case et al., EPOCH CHEMOTHERAPY FOR RECURRENT LYMPHOMA, Blood, 90(10), 1997, pp. 3972-3972
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS AND NON-HODGKINS-LYMPHOMA - A 10-YEAR EXPERIENCE AT ONE INSTITUTION
Authors: AULT KA CASE DC BOYD MA ERVIN TJ ARONSON FR EBRAHIM KS HILLMAN RS
Citation: Ka. Ault et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS AND NON-HODGKINS-LYMPHOMA - A 10-YEAR EXPERIENCE AT ONE INSTITUTION, Blood, 90(10), 1997, pp. 4546-4546
PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS
Authors: SPARANO JA FISHER RI WEISS GR MARGOLIN K ARONSON FR HAWKINS MJ ATKINS MB DUTCHER JP GAYNOR ER BOLDT DH DOROSHOW JH ERNEST ML SZNOL M MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA
Authors: MARGOLIN K ARONSON FR SZNOL M ATKINS MB GUCALP R FISHER RI SUNDERLAND M DOROSHOW JH ERNEST ML MIER JW DUTCHER JP GAYNOR ER WEISS GR
Citation: K. Margolin et al., PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 147-153
A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA
Authors: HAWKINS MJ ATKINS MB DUTCHER JP FISHER RI WEISS GR MARGOLIN KA RAYNER AA SZNOL M PARKINSON DR PAIETTA E GAYNOR ER BOLDT DH DOROSHOW JH ARONSON FR
Citation: Mj. Hawkins et al., A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 74-78
MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA
Authors: ATKINS MB OBOYLE KR SOSMAN JA WEISS GR MARGOLIN KA ERNEST ML KAPPLER K MIER JW SPARANO JA FISHER RI ECKARDT JR PEREIRA C ARONSON FR
Citation: Mb. Atkins et al., MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA, Journal of clinical oncology, 12(8), 1994, pp. 1553-1560
NEPHRECTOMY FOR METASTATIC RENAL-CELL CARCINOMA - A COMPONENT OF SYSTEMIC TREATMENT REGIMENS
Authors: WOLF JS ARONSON FR SMALL EJ CARROLL PR
Citation: Js. Wolf et al., NEPHRECTOMY FOR METASTATIC RENAL-CELL CARCINOMA - A COMPONENT OF SYSTEMIC TREATMENT REGIMENS, Journal of surgical oncology, 55(1), 1994, pp. 7-13
PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS
Authors: SOSMAN JA WEISS GR MARGOLIN KA ARONSON FR SZNOL M ATKINS MB OBOYLE K FISHER RI BOLDT DH DOROSHOW J ERNEST ML FISHER SG MIER J VACHINO G CALIENDO G
Citation: Ja. Sosman et al., PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS, Journal of clinical oncology, 11(8), 1993, pp. 1496-1505
RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA
Authors: SPARANO JA FISHER RI SUNDERLAND M MARGOLIN K ERNEST ML SZNOL M ATKINS MB DUTCHER JP MICETICH KC WEISS GR DOROSHOW JH ARONSON FR RUBINSTEIN LV MIER JW
Citation: Ja. Sparano et al., RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA, Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
Risultati: 1-10 |